Improve the quality of life of arrhythmia patients and cardiac arrest survivors.
Promote a environmentally sustainable, patient-centred ICD design.
Improve the accuracy of ICDs to prevent unintended impulse delivery due to random artefacts detection.
Improve the safety of ICDs by reducing risks of lead fracture and circumventing need for subsequent surgical intervention
Improve environmental sustainability by championing next generationof chargeable ICDs
Improve the quality of life of younger and athlete patients by reducing physical activity hinderances through miniaturisation of ICDs
In the design of our new generation of modified ICDs, our group compared the current generation of intravenous and subcutaneous ICDs. We carried out a thorough evaluation of these following areas:
Placement - Implantation of ICD
Functionality - Device and Patient Compatibility
Risks - Surgical Interventions and Infection-related
Design - Battery Life and Lifespan
Limitations - Areas for Improvement
Figure 36: Implantation of transvenous ICD in a patient
(Asamura et al., 2014)
Figure 37: Comparison of Transvenous and Subcutaneous ICDs
(Mayo Clinic, n.d.)
Table 5: Comparison of Transvenous and Subcutaneous ICDs
Table 6: Limitations and their Corresponding Modifications and Intended Outcomes
Figure 38: Implanted Subcutaneous ICD
(Köbe et al., 2013)
Table 7: Limitations and their Corresponding Benefits and Challenges
Summary of other Challenges
Creating the next generation of ICDs is challenging. The proliferation of our this next generation of ICD is subjected to multiple regulations in different countries for even initiating its research and manufacturing thereafter.
Research
Research and screening of multiple biomaterials must be conducted suitable for the manufacturing of the next-gen ICD leads. Further testing of the durability and biocompatibility of new materials have to be conducted.
Research on the inclusion of biosensors and the miniaturisation of both the biosensors and the device prototype itself have to be studied.
Cost
Research, acquisition and proliferation of biomaterials for lead have to be done which will incur a hefty cost.
Regulations
Countries with stricter regulations and safety protocols may take years before allowing the first implantation of the next-gen ICD.
Manufacturing
New factories and technology have to be built and implemented in order to manufacture next-gen ICDs.
Acceptance
It will take time to educate doctors and healthcare affiliates on the implantation, benefits and risks of the next-gen ICD.
Private doctors may be skeptical of executing surgical operations to patients to implant next-gen ICD due to it being a new technology to avoid conflicts.
Patients may be scared to undergo surgery regarding implantation of next-gen ICDs. This will require nation-wide education to increase public acceptance of this new technology.